<DOC>
	<DOC>NCT02563834</DOC>
	<brief_summary>Studies of myocardial fuel selection using a novel palmitate-based PET probe</brief_summary>
	<brief_title>A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism</brief_title>
	<detailed_description>A novel Positron Emission Tomography (PET) probe, 16- 18-F-fluoro-4-thiapalmitate, will be used to evaluate myocardial atty acid uptake. Studies will be done in humans with type 2 diabetes mellitus, and in controls. Studies will take place on 2 separate days, under fasting conditions and under insulin clamp conditions.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Lean: BMI&lt;25 kg/m2 normal glucose tolerance by 75g oral glucose tolerance test Type 2 diabetes mellitus: BMI &gt;25 kg/m2 previously diagnosed type 2 diabetes mellitus on oral and/or injected insulin treatment. Lean: *Use of any chronic medications Type 2 diabetes mellitus known microvascular disease known coronary or other macro vascular disease use of PPARgamma class antidiabetic agents within 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>